Conestoga Capital Advisors’s OrthoPediatrics KIDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.02M Buy
64,535
+16,325
+34% +$285K 0.02% 80
2025
Q4
$856K Sell
48,210
-15,185
-24% -$266K 0.01% 86
2025
Q3
$1.17M Sell
63,395
-3,193
-5% -$65.8K 0.02% 84
2025
Q2
$1.43M Buy
66,588
+12,795
+24% +$277K 0.02% 78
2025
Q1
$1.32M Hold
53,793
0.02% 78
2024
Q4
$1.25M Sell
53,793
-60
-0.1% -$1.5K 0.02% 82
2024
Q3
$1.46M Buy
53,853
+5,380
+11% +$163K 0.02% 76
2024
Q2
$1.39M Sell
48,473
-180
-0.4% -$5.52K 0.02% 78
2024
Q1
$1.42M Buy
48,653
+3,300
+7% +$92.3K 0.02% 81
2023
Q4
$1.47M Buy
45,353
+8,770
+24% +$254K 0.02% 76
2023
Q3
$1.17M Buy
36,583
+4,400
+14% +$169K 0.02% 80
2023
Q2
$1.41M Hold
32,183
0.02% 73
2023
Q1
$1.43M Hold
32,183
0.02% 77
2022
Q4
$1.28M Hold
32,183
0.02% 79
2022
Q3
$1.49M Hold
32,183
0.03% 75
2022
Q2
$1.39M Hold
32,183
0.03% 79
2022
Q1
$1.74M Buy
32,183
+28
+0.1% +$1.43K 0.03% 77
2021
Q4
$1.93M Buy
32,155
+60
+0.2% +$3.73K 0.03% 81
2021
Q3
$2.1M Sell
32,095
-4,900
-13% -$318K 0.03% 77
2021
Q2
$2.34M Sell
36,995
-4,925
-12% -$283K 0.03% 78
2021
Q1
$2.04M Buy
41,920
+6,600
+19% +$317K 0.03% 78
2020
Q4
$1.46M Buy
35,320
+6,425
+22% +$295K 0.02% 87
2020
Q3
$1.33M Buy
28,895
+1,275
+5% +$59.2K 0.03% 85
2020
Q2
$1.21M Buy
27,620
+11,675
+73% +$525K 0.03% 82
2020
Q1
$632K Sell
15,945
-1,175
-7% -$52.7K 0.02% 83
2019
Q4
$804K Buy
17,120
+6,300
+58% +$244K 0.02% 85
2019
Q3
$382K Buy
10,820
+425
+4% +$14.7K 0.01% 107
2019
Q2
$405K Buy
10,395
+440
+4% +$17.7K 0.01% 107
2019
Q1
$440K Buy
+9,955
New +$379K 0.01% 101

Other funds holding KIDS

Conestoga Capital Advisors's KIDS Position: Q1 2026 in Review

Conestoga Capital Advisors increased its OrthoPediatrics (KIDS) stake by 34% in Q1 2026, buying an estimated $285K and bringing the position to 64,535 shares worth $1.02M. The position accounts for 0.02% of the portfolio, ranked #80.

Conestoga Capital Advisors first reported a position in KIDS in Q1 2019 and has held it in 29 quarters since. The position peaked at $2.34M in Q2 2021. 121 funds tracked by Wall St. Rank hold KIDS as of Q1 2026.

  • Conestoga Capital Advisors held 64,535 shares of OrthoPediatrics worth $1.02M as of Q1 2026.
  • Conestoga Capital Advisors bought 16,325 OrthoPediatrics shares in Q1 2026, an estimated $285K.
  • OrthoPediatrics made up 0.02% of Conestoga Capital Advisors's portfolio in Q1 2026, its #80 holding.
  • Conestoga Capital Advisors first reported a position in OrthoPediatrics in Q1 2019 and has held it in 29 quarters since.
  • Conestoga Capital Advisors's OrthoPediatrics position peaked at $2.34M in Q2 2021.
  • 121 funds tracked by Wall St. Rank held OrthoPediatrics as of Q1 2026.

Based on Conestoga Capital Advisors's 13F filing for Q1 2026, filed 24 Apr 2026.